Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group
about
Budesonide for induction of remission in Crohn's diseaseAminosalicylates for induction of remission or response in Crohn's diseaseBudesonide for induction of remission in Crohn's diseaseInterventions for growth failure in childhood Crohn's diseaseAminosalicylates for induction of remission or response in Crohn's diseasePharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsInteraction of obesity and inflammatory bowel diseaseNew steroids and new salicylates in inflammatory bowel disease: a critical appraisalGlucocorticoid activation of Na(+)/H(+) exchanger isoform 3 revisited. The roles of SGK1 and NHERF2Therapeutic benefits of budesonide in gastroenterologySwitch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's diseaseOral budesonide in the management of Crohn's disease.Medical management of Crohn's disease: current therapy and recent advances.Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease.Management of Crohn's disease.Extraintestinal manifestations and complications in inflammatory bowel diseases.Collagenous enterocolitis and maturity onset type 1 diabetes manifesting as uraemia, malabsorption and extreme weight loss.Medical management of Crohn's disease.Review article: the management of severe Crohn's disease.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST).Review article: medical treatment of active Crohn's disease.The effectiveness of budesonide therapy for Crohn's disease.Role of conventional therapies in the era of biological treatment in Crohn's disease.Infliximab therapy in pediatric Crohn's disease: a review.Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates acute activation of Na+/H+ exchanger NHE3 by glucocorticoids.The use of glucocorticoids in marmoset wasting syndromeGastrointestinal bleeding as a complication of serial transverse enteroplasty.Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.State of the art: IBD therapy and clinical trials in IBD.Clinical outcomes and predictive factors for response after the first course of corticosteroid therapy in patients with Crohn's diseaseGlucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.Treatment of inflammatory bowel disease: a review of medical therapy.Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.Infliximab extends the duration until the first surgery in patients with Crohn's disease.Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.Budesonide for Crohn's disease.Second Korean guidelines for the management of Crohn's disease.
P2860
Q24187309-4289C621-4A8E-4595-B31E-92716E97DA5CQ24235730-5FBD54D5-5B88-4ED7-B534-2F779F218CC7Q24242729-B700C178-7DBD-4B24-9CBB-ACEBAE033978Q24246404-C182AD12-90C5-41D3-A3DA-72E8392E898BQ26471183-8267DE29-2C80-43F1-AF17-014A44DFB997Q26768280-3DA23D81-F13C-49E9-9067-95E7C98EA5CEQ28072225-6FDDC452-1A0D-416D-92EA-57EFCF459E56Q28192793-FA6AEE1F-2B1F-4DFF-B771-94B6449580B4Q28212817-D3A88E89-458C-415D-9959-4D888CCFF5E4Q28281682-BECD71A6-2702-47AF-993F-7B886909700FQ28345937-44D9E888-7884-43A9-84B6-FA72F120F03BQ30311870-E3E10F30-CFDD-42A4-AD75-DD871DF94A36Q30450875-C643F3B3-ACBD-4315-9080-D354AC433B2EQ31795152-137EFF4D-88AE-4D70-9D6D-B02B515E9525Q33785519-D2F14499-C3A4-4C13-9617-B69BEBC83043Q33866998-1254A87A-2664-4EB1-AC39-4B382372C08BQ33955999-0E7E4669-6C5C-40AA-A0C7-748068D93A9DQ34046139-70DB93C9-1241-46C9-92EC-A4246665A3B1Q34235823-E5B182F9-BE5A-4B69-98CB-17C7CFC915F5Q34564902-49E83F8F-B892-4E4A-9D88-F289ED76DE2FQ34649548-95B75A89-BD4F-4424-866A-61923EFBE33DQ34669225-37C027B2-3ACA-40E0-8AF8-49A9749DFDE7Q34786715-3E27C893-3247-4D22-9F59-7980FBA3D5D7Q34831072-18DA0C0A-A587-46ED-AF9A-8A5B667A4164Q35026358-57EF2EE0-D4FB-4424-B452-5337213B154CQ35340637-91A39933-5821-4004-9D7F-21E3F9A52647Q35557054-94604876-B46F-4DC4-B3AC-E4E68F056BCFQ35744391-5F1EFF99-9B68-4BB3-BB26-50014C035845Q35913934-DA01CED6-C61C-46C0-85A0-E445E75E40ECQ36299319-DFD55A57-0E7A-4CC0-83DA-376CC21C9C1FQ36609559-9DF2EFB4-1A57-4803-AC71-47E5D821B67BQ36659176-27C5C877-0C28-4373-A0B2-3E63F4CD39C4Q37058862-1340E4C9-3FC3-4612-A8B7-8F592CCC6B88Q37142095-6DC74D2C-D5E6-4916-82BE-A034C678BC8BQ37180423-5FE3952F-7D5E-4B2A-9721-F1B9AA71A093Q37284600-8FABAE3B-580E-447F-B4BA-E77124AEEF36Q37382433-7F485FCB-E4C6-46CA-B73B-2CC065FBDB2EQ37414672-34900D10-9AC3-48F7-A091-26C0B96D1B7EQ37554383-1857BB65-3EEB-436D-A2CA-CDE7BE8E0E19Q37662498-941796B1-DE05-4A2D-8552-E93F21AF9B48
P2860
Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Oral budesonide is as effectiv ...... Global Budesonide Study Group
@ast
Oral budesonide is as effectiv ...... Global Budesonide Study Group
@en
type
label
Oral budesonide is as effectiv ...... Global Budesonide Study Group
@ast
Oral budesonide is as effectiv ...... Global Budesonide Study Group
@en
prefLabel
Oral budesonide is as effectiv ...... Global Budesonide Study Group
@ast
Oral budesonide is as effectiv ...... Global Budesonide Study Group
@en
P2093
P2860
P356
P1433
P1476
Oral budesonide is as effectiv ...... Global Budesonide Study Group
@en
P2093
P2860
P304
P356
10.1136/GUT.41.2.209
P407
P577
1997-08-01T00:00:00Z